None
Quote | Invitro Intl (OTCMKTS:IVRO)
Last: | $0.0547 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0547 |
Close: | $0.0547 |
High: | $0.0547 |
Low: | $0.0547 |
Volume: | 1,150 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | Invitro Intl (OTCMKTS:IVRO)
Placentia, California--(Newsfile Corp. - February 14, 2024) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies, announced first Quarter FY '24 sales ending December 31, 2023, of $211,625 up 1.1% vs. the...
Placentia, California--(Newsfile Corp. - November 13, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies, announced sales for FY '23 ending September 30, 2023 of $792,629 ( -7% vs FY '22); net inc...
Message Board Posts | Invitro Intl (OTCMKTS:IVRO)
Subject | By | Source | When |
---|---|---|---|
new blog post about $IVRO. I think | NoNameStocks | investorshub | 12/01/2022 6:55:36 AM |
https://www.otcmarkets.com/stock/$IVRO/news/$IVRO-Explores-Opportunity-for-Growth? | bobkubecka | investorshub | 11/16/2022 2:38:09 PM |
i believe that statement is 'just' referring to | db7 | investorshub | 10/31/2022 12:58:11 PM |
Liquidation: The table below provides information regarding Officers, Directors, | StockLogistics | investorshub | 10/31/2022 11:58:52 AM |
$IVRO $IVRO with a Mission to Help | Thugmuffin | investorshub | 05/04/2022 9:57:02 AM |
News, Short Squeeze, Breakout and More Instantly...
Placentia, California--(Newsfile Corp. - February 14, 2024) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies, announced first Quarter FY '24 sales ending December 31, 2023, of $211,625 up 1.1% vs. the...
Placentia, California--(Newsfile Corp. - November 13, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38-year-old pioneer developer and marketer of globally approved NON-Animal test technologies, announced sales for FY '23 ending September 30, 2023 of $792,629 ( -7% vs FY '22); net inc...
Placentia, California--(Newsfile Corp. - August 9, 2023) - Today, InVitro International (OTC Pink: IVRO), the 38 year pioneer developer and marketer of animal free testing methods, announced Fiscal 2023 third quarter sales of $199,855, off 16% from prior year's third quarter. However, the net l...